1. Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-κB.
- Author
-
Ettelaie C, Fountain D, Collier ME, Elkeeb AM, Xiao YP, and Maraveyas A
- Subjects
- Cell Line, Tumor, Epidermal Growth Factor pharmacology, Epidermal Growth Factor physiology, Fibroblast Growth Factor 2 pharmacology, Fibroblast Growth Factor 2 physiology, Genes, Reporter, Humans, Luciferases biosynthesis, Luciferases genetics, Protein Transport, Real-Time Polymerase Chain Reaction, Thromboplastin genetics, Transcriptional Activation, Vascular Endothelial Growth Factor A pharmacology, Vascular Endothelial Growth Factor A physiology, Down-Regulation drug effects, Gene Expression drug effects, Heparin, Low-Molecular-Weight pharmacology, NF-kappa B metabolism, Receptors, Growth Factor metabolism, Thromboplastin metabolism
- Abstract
Treatment of cancer patients with low molecular weight heparin (LMWH) appears to have beneficial effects. In this study, the influence of low molecular weight heparin (LMWH) on tissue factor (TF) expression and activity in five cell lines from various tissues was analysed and explored. Incubation of cells with LMWH (0-2000μg/ml) resulted in the downregulation of TF mRNA expression which was both LMWH concentration-dependent and time-dependent. Downregulation of TF was also measured as decreased cellular TF antigen and activity. Consistently, incubation of cells with LMWH suppressed the nuclear localisation and the transcriptional activity of NFκB. Decreased TF mRNA was largely achievable by incubating the cells with an NFκB inhibitor alone whilst incubation with betulinic acid to activate NFκB reversed the inhibitory influence of LMWH. Cells were also incubated with a range of concentrations of EGF (0-10ng/ml), bFGF (0-20ng/ml) or VEGF (0-4ng/ml) in the presence or absence of LMWH (200μg/ml) for 24h and TF antigen measured. Inclusion of LMWH reduced TF expression in response to EGF, bFGF or VEGF but TF expression was partially restored by increasing concentrations of the growth factors. We conclude that LMWH downregulates TF expression in vitro through a mechanism that involves interference with the function of growth factors which in turn is mediated through the downregulation of the transcriptional activity of NFκB. This mechanism may also explain some of the beneficial influences attributed to LMWH therapy in the treatment of cancer patients., (Copyright © 2011 Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF